Positive Pulse: Expert Commentaries From CROI 2010

Faculty

Needs Statement

Scientific conferences such as the Conference on Retroviruses and Opportunistic Infections 2010 (CROI 2010) provide attendees with the most current updates on developments in HIV management; these data are critical to practitioners in their clinical settings. The updates, presented by leading experts in the field of HIV research, give insights into the most effective treatment regimens and management strategies, arming HIV health care providers (HCPs) with knowledge they can use to optimize patient outcomes. However, not all HIV HCPs can attend these conferences, thus there is a need for the crucial information presented at such meetings to be effectively communicated to a larger audience of HIV HCPs.
This CME activity provides expert commentaries on the highlights of clinically relevant data presented at CROI 2010. This activity provides participants with important information regarding the latest findings on initiation of treatment and effects on complications and comorbidities, the potential benefits of expanded HIV testing and treatment, new agents in development, and new data from clinical trials.

This issue of POSITIVE PULSE is an independent CME/CE-certified activity commenting on findings from CROI 2010 and is not an official publication of the conference.

 

Target Audience

This activity is designed for health care practitioners (physicians, physician assistants, nurse practitioners, registered nurses) involved in the management of HIV patients.

Objectives

1. Determine the impact recent developments in the field of HIV research, including epidemiology, transmission, access/linkage to care, and updates to treatment guidelines, will have on patients in care;
2. Integrate the latest data from clinical trials regarding the use of existing and novel antiretroviral agents into current clinical paradigms to improve HIV treatment outcomes;
3. Implement strategies, based in new data on HIV- and ARV-associated comorbidities, to treat and address the whole-health care needs of patients with HIV.

Accreditation

CME
This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship of the University of Kentucky College of Medicine and HealthmattersCME. The University of Kentucky College of Medicine is accredited by the ACCME to provide continuing medical education for physicians.

The University of Kentucky College of Medicine designates this educational activity for a maximum of 1.00 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

The University of Kentucky College of Medicine presents this activity for educational purposes only. Participants are expected to utilize their own expertise and judgment while engaged in the practice of medicine. The content of the presentations is provided solely by presenters who have been selected for presentations because of recognized expertise in their field.

CNE
The University of Kentucky, College of Nursing is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation (ANCC).

The Kentucky Board of Nursing (KBN) approves The University of Kentucky College of Nursing (UKCON) as a provider. ANCC and KBN approval of a continuing nursing education provider does not constitute endorsement of program content nor commercial sponsors. This educational activity is offered for a maximum of 1.00 ANCC and 1.2 KBN contact hour(s) for nurses who complete the entire program. Provider #: 3-0008-01-13-242. Certificates may be printed once the program is completed.

University of Kentucky College of Nursing is a provider approved by the California Board of Registered Nursing, Provider 00340864.

Faculty Disclosure

Dr. Sax is a consultant for Abbott, BMS, Gilead, Merck, Tibotec and Pfizer. He receives grant support from Tibotec and GSK.

Dr. Hodder is a consultant for Gilead and is on the advisory board for Gilead, Tibotec, and BI. Her spouse is a retired Merck executive.

Activity Sponsorship

This activity is jointly sponsored by the University of Kentucky and HealthmattersCME. Supported by an unrestricted educational grant from Bristol-Myers Squibb and Gilead Sciences Medical Affairs.